Med-Chemist

Med-Chemist : "Quintessential Medicinal Chemistry"

Showing posts with label -altered Pediatric Low-Grade Glioma. Show all posts
Showing posts with label -altered Pediatric Low-Grade Glioma. Show all posts
Saturday, September 28, 2024

FDA Grants Accelerated Approval for Ojemda (tovorafenib) for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma

›
Day One Biopharmaceuticals, Inc. (Nasdaq: DAWN) (“Day One” or the “Company”), a commercial-stage biopharmaceutical company dedicated to deve...
›
Home
View web version

Contributors

  • Dr. Umesh..
  • https://www.med-chemist.com
Powered by Blogger.